Metsera has brought in over $500m in funding in just seven months as it looks to enter the competitive weight loss arena.

Orderful has raised $15 million with NewRoad Capital Partners to help expand Orderful’s offerings, including self-service EDI ...

There is also an oral GLP-1 RA peptide called MET-002, a product of Metsera’s platform for optimizing the oral delivery of ...

Despite crowding in the next-gen weight loss space, Metsera has raised over $500 million since its April launch, indicating a ...

Global Partners LP (NYSE:GLP) Q3 2024 Earnings Call Transcript November 8 ... As of September 30, we have $219.2 million ...

The sizeable new round follows the announcement of phase 1 data for its lead asset MET-097i in September, and according to ...

New York-based Metsera, a biopharma developing medicines for obesity and metabolic diseases, has closed a $215 million Series ...

Greenhaven Road Capital Fund returned approximately +15% net during the third quarter, bringing year-to-date returns to ...

Good day, everyone, and welcome to the Global Partners Third Quarter 2024 Financial Results Conference ... As of September 30, we have $219.2 million borrowings outstanding on our working capital ...

CAMBRIDGE, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology ...